Pharmacokinetics and pharmacodynamics of newer macrolides

被引:92
作者
Nightingale, CH
机构
关键词
azithromycin; clarithromycin; erythromycin; concentration-independent; concentration-dependent;
D O I
10.1097/00006454-199704000-00027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Requirements for the antimicrobial activity of an antibiotic are: (1) binding of the drug to a specific site in the bacteria; (2) occupation of a critical number of binding sites; and (3) persistence at these binding sites for a sufficient time. With concentration-dependent antibiotics the ratio of the peak serum drug concentration to the MIC of a pathogen is the primary determinant of bacterial killing; with concentration-independent antibiotics it is the length of time serum concentration remains above the MIG, rather than the peak level. The pharmacokinetics of the new macrolides azithromycin and clarithromycin differ notably from those of conventional antibiotics in a more rapid and extensive distribution to body tissues. Because of these unique tissue pharmacokinetics, the pharmacodynamic models that apply to other classes of antibiotics may not explain the antimicrobial activity and clinical efficacy of azithromycin and clarithromycin.
引用
收藏
页码:438 / 443
页数:6
相关论文
共 29 条
[1]  
BALDWIN DR, 1990, EUR RESPIR J, V3, P886
[2]   IN-VITRO ACTIVITIES OF 12 ORALLY-ADMINISTERED ANTIMICROBIAL AGENTS AGAINST 4 SPECIES OF BACTERIAL RESPIRATORY PATHOGENS FROM US-MEDICAL-CENTERS IN 1992 AND 1993 [J].
BARRY, AL ;
PFALLER, MA ;
FUCHS, PC ;
PACKER, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2419-2425
[3]  
CARR RA, 1996, 3 INT C MACR AZ STRE
[4]   ONCE-A-WEEK AZITHROMYCIN IN AIDS PATIENTS - TOLERABILITY, KINETICS, AND EFFECTS ON ZIDOVUDINE DISPOSITION [J].
CHAVE, JP ;
MUNAFO, A ;
CHATTON, JY ;
DAYER, P ;
GLAUSER, MP ;
BIOLLAZ, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1013-1018
[5]   ABSOLUTE BIOAVAILABILITY OF CLARITHROMYCIN AFTER ORAL-ADMINISTRATION IN HUMANS [J].
CHU, SY ;
DEATON, R ;
CAVANAUGH, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1147-1150
[6]  
CRAIG W, 1992, 32 INT C ANT AG CHEM, P118
[7]  
FERRERO JL, 1990, DRUG METAB DISPOS, V18, P441
[8]   The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension [J].
Foulds, G ;
Luke, DR ;
Teng, R ;
Willavize, SA ;
Friedman, H ;
Curatolo, WJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 :37-44
[9]   THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].
FOULDS, G ;
SHEPARD, RM ;
JOHNSON, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82
[10]   PHARMACOKINETICS OF A CLARITHROMYCIN SUSPENSION IN INFANTS AND CHILDREN [J].
GAN, VN ;
CHU, SY ;
KUSMIESZ, HT ;
CRAFT, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) :2478-2480